While several studies have suggested a role for the forces a cell experiences while in vascular flow, FSS, in creating more aggressive metastatic tumors, the underlying genotypic and phenotypic changes that are altered when ER+ breast cancer cells are exposed to FSS have not been fully elucidated. This evidence concerns the gene ESR1 and metastatic neoplasm.